Conferences
The Making of Epitopea, a New Transatlantic Cancer Immunotherapeutics Venture
Life Sciences British Columbia, in collaboration with IRICoR, offered their 7th Annual Access to Innovation Conference on February 16, 2022.
Dr. Claude Perreault, Principal Investigator at IRIC, Director of the Immunobiology Research Unit and Full Professor at the Faculty of Medicine of the Université de Montréal, participated as a panelist.
The topic of the discussion is: “The Making of Epitopea, a New Transatlantic Cancer Immunotherapeutics Venture”.
